| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.17▲ | 2.16▲ | 2.14▲ | 2.08▲ | 2.33▼ |
| MA10 | 2.16▲ | 2.12▲ | 2.11▲ | 2.14▲ | 2.48▼ |
| MA20 | 2.12▲ | 2.08▲ | 2.05▲ | 2.34▼ | 2.72▼ |
| MA50 | 2.05▲ | 2.15▲ | 2.21▼ | 2.57▼ | 3.05▼ |
| MA100 | 2.21▼ | 2.34▼ | 2.40▼ | 2.75▼ | 3.82▼ |
| MA200 | 2.38▼ | 2.61▼ | 2.69▼ | 3.02▼ | 8.97▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.022▲ | 0.029▲ | -0.012▼ | -0.051▼ |
| RSI | 57.799▲ | 62.849▲ | 58.631▲ | 43.484▼ | 36.993▼ |
| STOCH | 74.722 | 69.718 | 70.685 | 33.609 | 9.589▼ |
| WILL %R | -20.000▲ | -18.750▲ | -17.647▲ | -49.315 | -94.973▼ |
| CCI | 51.639 | 87.114 | 114.671▲ | -12.103 | -105.212▼ |
|
Saturday, August 16, 2025 05:13 AM
August 14, 2025Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.55. Operator: Welcome to the conference call hosted by Daré Bioscience Therapeutics ...
|
|
Friday, August 15, 2025 02:23 AM
DARE to PLAY Sildenafil Cream on Track for Q4 2025 Launch via 503B Compounding Pathway; Positioned for Product Revenue Beginning in Q4 2025 Positive Interim DSMB Outcome for Ovaprene® Phase 3 Study Su ...
|
|
Friday, August 15, 2025 12:47 AM
Dare Bioscience Inc (DARE) progresses with key product launches and pipeline developments, despite facing financial hurdles and market competition.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 2.19 | 2.35 | 2.05 | 2.20 | 400,391 |
| 14/08/25 | 2.10 | 2.17 | 2.03 | 2.07 | 262,879 |
| 13/08/25 | 2.02 | 2.13 | 2.02 | 2.11 | 222,926 |
| 12/08/25 | 1.98 | 2.0793 | 1.955 | 2.03 | 254,530 |
| 11/08/25 | 1.94 | 2.00 | 1.88 | 1.97 | 218,076 |
| 08/08/25 | 2.03 | 2.05 | 1.83 | 1.92 | 412,357 |
| 07/08/25 | 2.26 | 2.28 | 2.00 | 2.04 | 680,727 |
| 06/08/25 | 2.37 | 2.40 | 2.18 | 2.26 | 442,890 |
| 05/08/25 | 2.40 | 2.4383 | 2.38 | 2.40 | 101,165 |
| 04/08/25 | 2.41 | 2.4991 | 2.38 | 2.39 | 174,480 |
|
|
||||
|
|
||||
|
|